GLP-1 Medications

Semaglutide:

• Helps regulate appetite signals in the brain

• Slows gastric emptying, which may promote feelings of fullness

• Supports blood sugar regulation

• Is administered according to a provider-directed dosing schedule

Individual results vary. Not everyone is a candidate. A medical consultation is required.

Important Safety Information

Semaglutide is a prescription medication and is not appropriate for everyone. It may cause side effects, including gastrointestinal symptoms. A full medical evaluation is required to determine eligibility. Patients should discuss potential risks, benefits, and alternatives with their provider.

Semaglutide may be considered for adults who meet certain medical criteria and are evaluated by a licensed healthcare provider.

You may be a candidate if you:

• Have a Body Mass Index (BMI) of 30 or higher, or

• Have a BMI of 27 or higher with at least one weight-related condition such as high blood pressure, type 2 diabetes, or high cholesterol

• Have struggled to achieve sustainable weight loss through diet and exercise alone

• Are willing to participate in a medically supervised weight management program

• Do not have contraindications based on your medical history

Eligibility is determined only after a medical consultation and review of your health history. Semaglutide is a prescription medication and is not appropriate for everyone.

Semaglutide may not be appropriate for individuals who:

• Have a personal or family history of medullary thyroid carcinoma

• Have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

• Are pregnant or planning pregnancy

• Have certain gastrointestinal or pancreatic conditions

A licensed provider will review your history to determine if treatment is appropriate.

Risks and Side Effects of Semaglutide

Semaglutide is a prescription GLP-1 medication and, like all medications, may cause side effects. Not everyone experiences adverse effects, but patients should be aware of potential risks before starting treatment.

Common Side Effects

The most frequently reported side effects are gastrointestinal and may include:

• Nausea

• Vomiting

• Diarrhea

• Constipation

• Abdominal discomfort

• Decreased appetite

These effects are often mild to moderate and may lessen as the body adjusts to treatment. Dose adjustments are determined by your medical provider.

Less Common but More Serious Risks

Although uncommon, semaglutide may be associated with:

• Pancreatitis

• Gallbladder problems

• Kidney complications related to dehydration

• Changes in blood sugar levels

• Possible risk of thyroid C-cell tumors (observed in animal studies)

Semaglutide is not recommended for individuals with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

Important Considerations

• Semaglutide is not appropriate for everyone.

• A full medical evaluation is required prior to treatment.

• Patients should disclose all medical conditions and medications.

• Ongoing medical monitoring is recommended during therapy.

Individual results and experiences vary. Treatment decisions should be made in consultation with a licensed healthcare provider

Tirzepatide is a prescription medication used under medical supervision to help manage blood sugar and, in certain patients, support weight management. It belongs to a newer class of medications that act on two hormone pathways:

• GLP-1 (glucagon-like peptide-1)

• GIP (glucose-dependent insulinotropic polypeptide)

Because it works on both receptors, it’s often referred to as a dual GLP-1/GIP receptor agonist.

Tirzepatide is a prescription medication that works by activating two hormone receptors involved in metabolic regulation:

• GLP-1 (glucagon-like peptide-1)

• GIP (glucose-dependent insulinotropic polypeptide)

Because it targets both pathways, tirzepatide is often referred to as a dual GLP-1/GIP receptor agonist.

1️⃣ Appetite Regulation

Tirzepatide acts on receptors in the brain that influence appetite signaling. This may help:

• Reduce hunger cues

• Increase feelings of fullness

• Support portion control

Individual responses vary.

2️⃣ Slows Gastric Emptying

The medication can slow how quickly food leaves the stomach, which may:

• Prolong satiety

• Help regulate post-meal blood sugar levels

This effect may lessen over time as the body adjusts.

3️⃣ Blood Sugar Support

Tirzepatide influences insulin and glucose regulation by:

• Enhancing glucose-dependent insulin secretion

• Reducing excess glucose production

• Improving overall glycemic control in appropriate patients

It is approved for certain adults with type 2 diabetes and may be prescribed for chronic weight management in eligible individuals.

4️⃣ Metabolic Effects

Through its combined GLP-1 and GIP activity, tirzepatide affects multiple metabolic pathways that influence:

• Energy balance

• Glucose regulation

• Hormonal signaling related to appetite

Treatment is individualized and requires medical supervision.

Important Considerations

• Tirzepatide is a prescription medication.

• Not everyone is a candidate.

• A medical consultation is required.

• Ongoing monitoring is recommended.

• Individual results vary.

Tirzepatide is a prescription medication that may be considered for certain adults as part of a medically supervised weight management or metabolic health program.

You may be a candidate if you:

• Have a Body Mass Index (BMI) of 30 or higher, or

• Have a BMI of 27 or higher with at least one weight-related medical condition (such as high blood pressure, type 2 diabetes, or high cholesterol)

• Have not achieved sustainable weight loss with lifestyle changes alone

• Are willing to participate in ongoing medical monitoring

• Do not have contraindications based on your medical history

Eligibility is determined only after a consultation with a licensed healthcare provider.

Candidates for Blood Sugar Management

Tirzepatide may also be prescribed for adults with type 2 diabetes to help improve glycemic control when clinically appropriate.

Important Notes

• Tirzepatide is available by prescription only.

• Not everyone who inquires will qualify.

• A full medical evaluation is required.

• Treatment plans are individualized.

• Ongoing supervision is recommended.

Individual results vary, and risks and benefits should be discussed with your provider.

Individuals Who May Not Be Candidates for Tirzepatide

Tirzepatide is a prescription medication and is not appropriate for everyone. A licensed healthcare provider must determine eligibility after a full medical evaluation.

Tirzepatide may not be recommended for individuals who:

• Have a personal or family history of medullary thyroid carcinoma (MTC)

• Have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

• Are pregnant, planning to become pregnant, or breastfeeding

• Have a history of pancreatitis

• Have severe gastrointestinal disease (such as severe gastroparesis)

• Have experienced a serious allergic reaction to tirzepatide or its components

• Have certain uncontrolled endocrine or metabolic conditions

• Are using other medications that may conflict with GLP-1/GIP therapy

Individuals with type 1 diabetes or a history of diabetic ketoacidosis are generally not candidates for tirzepatide.

Important Considerations

• Tirzepatide requires a prescription and medical supervision.

• A full review of your medical history, medications, and risk factors is required.

• Treatment decisions are individualized based on clinical evaluation.

• Not all patients who inquire about tirzepatide will qualify.

If you are unsure whether you may be a candidate, a consultation with a licensed provider is necessary to determine appropriateness.

Risks and Side Effects of Tirzepatide

Tirzepatide is a prescription GLP-1 and GIP receptor agonist. Like all medications, it may cause side effects. Not everyone experiences adverse effects, but patients should understand potential risks before starting treatment.

Common Side Effects

The most frequently reported side effects are gastrointestinal and may include:

• Nausea

• Vomiting

• Diarrhea

• Constipation

• Abdominal discomfort

• Decreased appetite

• Indigestion

These effects are often mild to moderate and may decrease as the body adjusts. Dose adjustments are determined by a licensed healthcare provider.

Less Common but More Serious Risks

Although uncommon, tirzepatide may be associated with:

• Pancreatitis

• Gallbladder problems (including gallstones)

• Kidney complications related to dehydration

• Changes in blood sugar levels

• Possible risk of thyroid C-cell tumors (observed in animal studies)

Tirzepatide is not recommended for individuals with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

Important Safety Information

• Tirzepatide is a prescription medication and is not appropriate for everyone.

• A full medical evaluation is required before starting therapy.

• Patients should disclose all medical conditions and medications.

• Ongoing medical supervision and monitoring are recommended during treatment.

Individual results and experiences vary. Treatment decisions should be made in consultation with a licensed healthcare provider.

Important Considerations for Tirzepatide Treatment

Tirzepatide is a prescription medication that must be used under the supervision of a licensed healthcare provider. Before starting therapy, several important factors should be reviewed to ensure safe and appropriate use.

Medical Evaluation Is Required

• Tirzepatide is available by prescription only.

• A full medical history, medication review, and clinical assessment are required.

• Not all individuals who inquire about treatment will qualify.

Eligibility is determined by a licensed provider based on BMI criteria, medical conditions, and risk factors.

Ongoing Monitoring

Patients receiving tirzepatide may require:

• Periodic follow-up visits

• Review of side effects and tolerance

• Monitoring of blood sugar levels (if applicable)

• Dose adjustments based on clinical response

Medical supervision is recommended throughout treatment.

Lifestyle Integration

Tirzepatide is generally intended to be used alongside:

• Nutrition guidance

• Physical activity

• Long-term behavioral modifications

Medication alone does not replace sustainable lifestyle habits.

Potential Risks

Patients should discuss:

• Personal or family history of thyroid cancer

• History of pancreatitis or gallbladder disease

• Gastrointestinal conditions

• Current medications and supplements

• Pregnancy or plans to become pregnant

Understanding potential risks and benefits is an essential part of the decision-making process.

Individual Results May Vary

• Response to treatment differs from person to person.

• Duration of therapy is determined by your provider.

• Treatment goals and outcomes are individualized.

What to Expect During Treatment

Semaglutide treatment is provided as part of a medically supervised weight management program. Your experience will be personalized based on your health history, treatment goals, and provider recommendations.

Initial Consultation and Evaluation

Before starting semaglutide, you will complete a medical consultation. Your licensed provider will:

• Review your medical history and current medications

• Assess BMI and weight-related health conditions

• Discuss potential risks, benefits, and alternatives

• Determine whether prescription GLP-1 therapy is appropriate

Semaglutide is a prescription medication and requires medical approval.

Starting Treatment

If prescribed, semaglutide is typically:

• Initiated at a lower dose

• Gradually adjusted based on tolerance

• Administered according to provider instructions

Gradual dose adjustments are often used to help reduce gastrointestinal side effects.

Follow-Up and Monitoring

Ongoing monitoring is an important part of treatment. This may include:

• Periodic check-ins

• Review of weight trends

• Evaluation of side effects

• Adjustments to dosing if needed

Patients should report any unusual symptoms to their provider promptly.

Lifestyle Integration

Semaglutide is generally used alongside:

• Nutrition guidance

• Physical activity

• Behavioral and lifestyle support

Sustainable weight management typically involves long-term healthy habits.

Important Considerations

1. Individual results vary.

2. Not everyone is a candidate.

3. Treatment duration is determined by your provider.

4. Medical supervision is required throughout therapy.